Prosecution Insights
Last updated: May 29, 2026

Dunlap Codding, P.C. - Novocure GmbH

10 pending office actions • 1 client • 7 examiners • 5 art units • 0 of 10 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days

Portfolio Summary

10
Total Pending OAs
7
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
3
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (3)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
10
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only10 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
20% of docket
1
Information Tech
10% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
7
Mechanical / Eng
70% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

100 h
Manual time on pending OAs
20 h
Time saved (low, 20%)
35 h
Time saved (mid, 35%)
0.9 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DINH, ANH-KHOA N 3 86.9% +14.5%
KAHELIN, MICHAEL WILLIAM 2 77.6% +24.0%
WEBSTER, KARMEL JOHANNA 1 61.1% +33.3%
BEHARRY, ZANNA MARIA 1 23.3% +54.0%
JACKSON-TONGUE, LAKIA J 1 68.8% +20.4%
SAHAND, SANA 1 62.3% +26.9%
CALLE, ANGEL JAVIER 1 68.6% +28.3%

Quick Wins (3)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18475497 INGESTIBLE IMPLANTABLE DEVICE TO MEASURE INTERNAL TTFIELD INTENSITY DINH, ANH-KHOA N 9d overdue
18337747 COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND VEGF INHIBITORS DINH, ANH-KHOA N 22d
18398714 COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND ANTI-VEGFR-2 ANTIBODIES DINH, ANH-KHOA N 34d

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18476573 COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND APOPTOTIC CANCER CELL VACCINATION BEHARRY, ZANNA MARIA 22d

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18523221 TRANSDUCER ARRAYS HAVING ALTERNATIVE ARRAY MATERIALS KAHELIN, MICHAEL WILLIAM 43d overdue
18470948 COMPOSITIONS, SYSTEMS, AND METHODS FOR REDUCING ELECTROSENSATION AND/OR SKIN IRRITATION JACKSON-TONGUE, LAKIA J 38d overdue
18475497 INGESTIBLE IMPLANTABLE DEVICE TO MEASURE INTERNAL TTFIELD INTENSITY DINH, ANH-KHOA N 9d overdue
18062372 GARMENT PROVIDING A BIASING FORCE ON A TRANSDUCER ARRAY SAHAND, SANA 8d overdue
17698777 CONSTRUCTING A 3D PHANTOM WITH LIQUID HYDROGEL CALLE, ANGEL JAVIER 3d overdue
18477142 SINGLE WIRE TEMPERATURE MEASUREMENT SOLUTION FOR A TTFIELD APPLICATION SYSTEM AND METHODS OF PRODUCTION AND USE THEREOF WEBSTER, KARMEL JOHANNA 14d
18476573 COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND APOPTOTIC CANCER CELL VACCINATION BEHARRY, ZANNA MARIA 22d
18337747 COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND VEGF INHIBITORS DINH, ANH-KHOA N 22d

Client Portfolio (1 client)

Client (Assignee)Pending OAs
NOVOCURE GMBH 10

Top Art Units

Art UnitApps
37964
37923
16321
16451
21891

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18398714 COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND ANTI-VEGFR-2 ANTIBODIES Novocure GmbH DINH, ANH-KHOA N 3796 §103 Final Rejection 34d Pending Dec 28, 2023
18523221 TRANSDUCER ARRAYS HAVING ALTERNATIVE ARRAY MATERIALS Novocure GmbH KAHELIN, MICHAEL WILLIAM 3792 §103 Non-Final OA 43d overdue Pending Nov 29, 2023
18511374 CONDUCTIVE GEL COMPOSITIONS COMPRISING BULK ELECTRON TRANSPORT AGENTS AND METHODS OF PRODUCTION AND USE THEREOF Novocure GmbH KAHELIN, MICHAEL WILLIAM 3792 §103 Non-Final OA 75d Pending Nov 16, 2023
18477142 SINGLE WIRE TEMPERATURE MEASUREMENT SOLUTION FOR A TTFIELD APPLICATION SYSTEM AND METHODS OF PRODUCTION AND USE THEREOF Novocure GmbH WEBSTER, KARMEL JOHANNA 3792 §103 Non-Final OA 14d Pending Sep 28, 2023
18476573 COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND APOPTOTIC CANCER CELL VACCINATION Novocure GmbH BEHARRY, ZANNA MARIA 1632 §103 Non-Final OA 22d Pending Sep 28, 2023
18475497 INGESTIBLE IMPLANTABLE DEVICE TO MEASURE INTERNAL TTFIELD INTENSITY Novocure GmbH DINH, ANH-KHOA N 3796 §103 Final Rejection 9d overdue Pending Sep 27, 2023
18470948 COMPOSITIONS, SYSTEMS, AND METHODS FOR REDUCING ELECTROSENSATION AND/OR SKIN IRRITATION Novocure GmbH JACKSON-TONGUE, LAKIA J 1645 §103 Non-Final OA 38d overdue Pending Sep 20, 2023
18337747 COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND VEGF INHIBITORS Novocure GmbH DINH, ANH-KHOA N 3796 §103 Final Rejection 22d Pending Jun 20, 2023
18062372 GARMENT PROVIDING A BIASING FORCE ON A TRANSDUCER ARRAY Novocure GmbH SAHAND, SANA 3796 §103 Non-Final OA 8d overdue Pending Dec 06, 2022
17698777 CONSTRUCTING A 3D PHANTOM WITH LIQUID HYDROGEL Novocure GmbH CALLE, ANGEL JAVIER 2189 §103 Non-Final OA 3d overdue Pending Mar 18, 2022

Managing Dunlap Codding, P.C. - Novocure GmbH's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month